RNXT
RenovoRx, Inc.
Company overview
- Market capitalization
- $69.95M
- Employees
- 17
- Latest publication
- 2026-09-29
About RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 909,000USD | 563,000USD | 238,000USD | 266,000USD | 422,000USD | 197,000USD | 43,000USD | 0USD |
| Cost Of Revenue | 143,000USD | 84,000USD | 28,000USD | 53,000USD | 152,000USD | 94,000USD | — | 0USD |
| Gross Profit | 766,000USD | 479,000USD | 210,000USD | 213,000USD | 270,000USD | 103,000USD | — | 0USD |
| Research Development | 1,200,000USD | 1,228,000USD | 1,501,000USD | 1,685,000USD | 1,426,000USD | 1,642,000USD | 1,576,000USD | 1,650,000USD |
| Selling General Administrative | 2,915,000USD | 2,720,000USD | 1,571,000USD | 1,728,000USD | 1,522,000USD | 1,571,000USD | 1,099,000USD | 1,178,000USD |
| Total Operating Expenses | 4,115,000USD | 3,948,000USD | 3,733,000USD | 3,413,000USD | 2,948,000USD | 3,213,000USD | 2,675,000USD | 2,828,000USD |
| Operating Income | -3,349,000USD | -3,469,000USD | -3,523,000USD | -3,200,000USD | -2,678,000USD | -3,110,000USD | -2,632,000USD | -2,828,000USD |
| Total Other Income Expense Net | 438,000USD | -52,000USD | 581,000USD | 288,000USD | -217,000USD | 690,000USD | -331,000USD | 357,000USD |
| Net Income | -2,911,000USD | -3,521,000USD | -2,941,000USD | -2,912,000USD | -2,895,000USD | -2,420,000USD | -2,878,000USD | -2,471,000USD |
| Interest Income | — | 45,000USD | 75,000USD | 113,000USD | 133,000USD | 106,000USD | — | 124,000USD |
| Net Interest Income | — | 45,000USD | 75,000USD | 113,000USD | 133,000USD | 106,000USD | 85,000USD | 124,000USD |
| Income Before Tax | — | -3,521,000USD | -2,942,000USD | -2,912,000USD | -2,895,000USD | -2,420,000USD | -2,878,000USD | -2,471,000USD |
| Net Income From Continuing Ops | — | -3,521,000USD | -2,942,000USD | -2,912,000USD | -2,895,000USD | -2,420,000USD | -2,878,000USD | -2,471,000USD |
| Ebitda | — | -3,469,000USD | -3,522,000USD | -3,200,000USD | -2,677,000USD | -2,419,000USD | — | -2,828,000USD |
| Reconciled Depreciation | — | 1,000USD | 1,000USD | -1,000USD | 1,000USD | 1,000USD | — | 0USD |
| Ebit | — | — | -3,523,000USD | -3,199,000USD | -2,678,000USD | -2,420,000USD | -2,632,000USD | -2,828,000USD |
| Depreciation And Amortization | — | — | 1,000USD | -1,000USD | 1,000USD | 1,000USD | — | — |
| Income Tax Expense | — | — | — | — | — | 2,476,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 1,123,000USD | 43,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 327,000USD | 0USD | 0USD | 6,000USD | 9,000USD | — | — |
| Gross Profit | 796,000USD | 43,000USD | 0USD | -6,000USD | -9,000USD | — | — |
| Research Development | 6,269,000USD | 6,025,000USD | 5,667,000USD | 4,301,000USD | 3,039,000USD | 2,386,000USD | 2,997,000USD |
| Selling General Administrative | 7,038,000USD | 4,988,000USD | 5,729,000USD | 5,649,000USD | 2,632,000USD | 818,000USD | 899,000USD |
| Total Operating Expenses | 13,306,000USD | 11,013,000USD | 11,396,000USD | 9,950,000USD | 5,671,000USD | 3,204,000USD | 3,896,000USD |
| Operating Income | -12,510,000USD | -10,970,000USD | -11,396,000USD | -9,950,000USD | -5,671,000USD | -3,204,000USD | -3,896,000USD |
| Interest Income | 427,000USD | 384,000USD | 111,000USD | 57,000USD | — | 3,000USD | 63,000USD |
| Net Interest Income | 427,000USD | 384,000USD | 111,000USD | 57,000USD | -834,000USD | -587,000USD | 63,000USD |
| Income Before Tax | -11,168,000USD | -8,814,000USD | -10,232,000USD | -9,889,000USD | -6,324,000USD | -3,798,000USD | -3,839,000USD |
| Net Income | -11,168,000USD | -8,814,000USD | -10,232,000USD | -9,771,000USD | -6,324,000USD | -3,798,000USD | -3,839,000USD |
| Net Income From Continuing Ops | -11,169,000USD | -8,814,000USD | -9,161,000USD | -9,889,000USD | -6,324,000USD | -3,798,000USD | -3,839,000USD |
| Ebitda | -12,510,000USD | -10,970,000USD | -11,390,000USD | -9,944,000USD | -5,481,000USD | -3,208,000USD | -3,839,000USD |
| Reconciled Depreciation | 2,000USD | 0USD | 0USD | 6,000USD | 9,000USD | 0USD | — |
| Total Other Income Expense Net | 1,342,000USD | 2,156,000USD | 1,164,000USD | 61,000USD | -653,000USD | -594,000USD | 57,000USD |
| Interest Expense | — | 384,000USD | 108,000USD | 57,000USD | 834,000USD | 590,000USD | 0USD |
| Income Tax Expense | — | -8,814,000USD | -6USD | -118,000USD | 772,000USD | 587,000USD | -63,000USD |
| Ebit | — | -10,970,000USD | -11,396,000USD | -9,950,000USD | -5,490,000USD | -6,412,000USD | -3,896,000USD |
| Depreciation And Amortization | — | — | 6,000USD | 6,000USD | 9,000USD | 3,204,000USD | 3,896,000USD |
| Net Income Applicable To Common Shares | — | — | — | -9,889,000USD | -6,324,000USD | -3,798,000USD | -3,839,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,472,000USD | 13,964,000USD | 8,095,000USD | 11,206,000USD | 13,643,000USD | 16,014,000USD | 8,118,000USD | 10,031,000USD |
| Cash And Equivalents | 9,479,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 10,810,000USD | 13,720,000USD | 7,893,000USD | 10,980,000USD | 13,395,000USD | 15,745,000USD | 7,828,000USD | 10,031,000USD |
| Other Current Assets | 153,000USD | 699,000USD | 541,000USD | 495,000USD | 718,000USD | 921,000USD | 303,000USD | 468,000USD |
| Other Non Current Assets | 200,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,493,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,884,000USD | 1,920,000USD | 1,962,000USD | 1,884,000USD | 1,556,000USD | 1,736,000USD | 1,909,000USD | 1,772,000USD |
| Other Current Liabilities | 1,018,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 8,979,000USD | 11,265,000USD | 5,422,000USD | 8,078,000USD | 10,641,000USD | 13,157,000USD | 4,478,000USD | 7,071,000USD |
| Total Equity Including Noncontrolling Interest | 8,979,000USD | — | — | — | — | — | — | — |
| Net Receivables | 480,000USD | 280,000USD | 139,000USD | 169,000USD | 363,000USD | 242,000USD | 43,000USD | — |
| Inventory | 383,000USD | 379,000USD | 189,000USD | 272,000USD | — | — | 0USD | — |
| Property Plant Equipment Net | 462,000USD | 244,000USD | 202,000USD | 226,000USD | 248,000USD | 269,000USD | 290,000USD | — |
| Accounts Payable | 866,000USD | 1,119,000USD | 799,000USD | 869,000USD | 671,000USD | 967,000USD | 586,000USD | 686,000USD |
| Short Term Debt | 131,000USD | — | — | 102,000USD | 99,000USD | 97,000USD | — | — |
| Common Stock | 5,000USD | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | — | 2,000USD |
| Retained Earnings | -67,819,000USD | -64,908,000USD | -61,387,000USD | -58,446,000USD | -55,534,000USD | -52,639,000USD | -50,219,000USD | -47,341,000USD |
| Total Liab | — | 2,699,000USD | 2,673,000USD | 3,128,000USD | 3,002,000USD | 2,857,000USD | 3,640,000USD | 2,960,000USD |
| Other Current Liab | — | 801,000USD | 1,163,000USD | 913,000USD | 786,000USD | 672,000USD | — | 1,086,000USD |
| Capital Stock | — | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 2,000USD | 2,000USD |
| Cash | — | 12,362,000USD | 7,024,000USD | 10,044,000USD | 12,314,000USD | 14,582,000USD | 7,154,000USD | 9,563,000USD |
| Cash And Short Term Investments | — | 12,362,000USD | 7,024,000USD | 10,044,000USD | 12,314,000USD | 14,582,000USD | — | 9,563,000USD |
| Net Debt | — | -12,284,000USD | -6,917,000USD | -9,808,000USD | -12,054,000USD | -14,299,000USD | — | -9,563,000USD |
| Short Long Term Debt Total | — | 78,000USD | 107,000USD | 236,000USD | 260,000USD | 283,000USD | — | — |
| Property Plant Equipment Gross | — | 247,000USD | 204,000USD | 228,000USD | 250,000USD | 270,000USD | 290,000USD | — |
| Common Stock Shares Outstanding | — | 38,032,421shares | 35,333,127shares | 36,646,278shares | 36,576,567shares | 31,395,888shares | 24,034,672shares | 24,940,746shares |
| Non Current Assets Total | — | 244,000USD | 202,000USD | 226,000USD | 248,000USD | 269,000USD | 290,000USD | 468,000USD |
| Non Current Liabilities Total | — | 779,000USD | 711,000USD | 1,244,000USD | 1,446,000USD | 1,121,000USD | 1,731,000USD | 1,188,000USD |
| Net Working Capital | — | 11,800,000USD | 5,931,000USD | 9,096,000USD | 11,839,000USD | 14,009,000USD | 5,919,000USD | 8,259,000USD |
| Unclassified Equity | — | 76,163,000USD | 66,801,000USD | 66,516,000USD | 66,167,000USD | 65,788,000USD | 54,695,000USD | 54,408,000USD |
| Unclassified Non Current Liabilities | — | — | — | 1,244,000USD | 1,446,000USD | 1,121,000USD | 1,731,000USD | 1,188,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | 0USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | 1,323,000USD | — |
| Other Assets | — | — | — | — | — | — | — | 468,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 8,095,000USD | 8,118,000USD | 1,466,000USD | 7,265,000USD | 16,287,000USD | 1,914,000USD | 2,270,000USD |
| Other Current Assets | 541,000USD | 631,000USD | 293,000USD | 825,000USD | 1,089,000USD | 115,000USD | 162,000USD |
| Total Liab | 2,673,000USD | 3,640,000USD | 4,466,000USD | 1,102,000USD | 938,000USD | 16,570,000USD | 805,000USD |
| Total Stockholder Equity | 5,422,000USD | 4,478,000USD | -3,000,000USD | 6,163,000USD | 15,349,000USD | -14,656,000USD | 1,465,000USD |
| Other Current Liab | 1,163,000USD | 1,257,000USD | 614,000USD | 568,000USD | 413,000USD | 1,167,000USD | 267,000USD |
| Common Stock | 4,000USD | 2,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 4,000USD | 2,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -61,387,000USD | -50,219,000USD | -41,405,000USD | -31,173,000USD | -21,284,000USD | -14,960,000USD | -11,162,000USD |
| Cash | 7,024,000USD | 7,154,000USD | 1,173,000USD | 4,391,000USD | 15,192,000USD | 1,795,000USD | 2,104,000USD |
| Cash And Short Term Investments | 7,024,000USD | 7,154,000USD | 1,173,000USD | 6,440,000USD | 15,192,000USD | 1,795,000USD | 2,104,000USD |
| Total Current Assets | 7,893,000USD | 7,828,000USD | 1,466,000USD | 7,265,000USD | 16,281,000USD | 1,910,000USD | 2,266,000USD |
| Total Current Liabilities | 1,962,000USD | 1,909,000USD | 1,175,000USD | 1,102,000USD | 938,000USD | 4,096,000USD | 805,000USD |
| Net Debt | -6,917,000USD | -6,876,000USD | -1,173,000USD | -4,391,000USD | -15,192,000USD | 995,000USD | -2,104,000USD |
| Short Long Term Debt Total | 107,000USD | 278,000USD | — | — | — | 2,790,000USD | 12,391,000USD |
| Net Receivables | 139,000USD | 43,000USD | 0USD | — | — | — | — |
| Inventory | 189,000USD | 0USD | — | — | — | — | — |
| Accounts Payable | 799,000USD | 586,000USD | 561,000USD | 534,000USD | 525,000USD | 162,000USD | 538,000USD |
| Property Plant Equipment Net | 202,000USD | 290,000USD | 0USD | 0USD | 6,000USD | 0USD | — |
| Property Plant Equipment Gross | 204,000USD | 290,000USD | 0USD | 0USD | 6,000USD | 0USD | — |
| Common Stock Shares Outstanding | 35,333,127shares | 23,605,955shares | 20,581,334shares | 18,103,452shares | 17,867,978shares | 17,323,732shares | 17,323,732shares |
| Non Current Assets Total | 202,000USD | 290,000USD | 100,999USD | 0USD | 6,000USD | 4,000USD | 4,000USD |
| Non Current Liabilities Total | 711,000USD | 1,731,000USD | 3,291,000USD | 568,000USD | 525,000USD | 12,474,000USD | 12,391,000USD |
| Net Working Capital | 5,931,000USD | 5,919,000USD | 291,000USD | 6,163,000USD | 15,343,000USD | -2,186,000USD | 1,461,000USD |
| Unclassified Equity | 66,801,000USD | 54,693,000USD | 35,403,000USD | 37,317,000USD | 52,918,000USD | — | 12,625,000USD |
| Short Term Debt | — | 66,000USD | — | — | — | 2,767,000USD | — |
| Unclassified Non Current Liabilities | — | 1,731,000USD | 3,291,000USD | — | — | 12,451,000USD | 12,391,000USD |
| Other Assets | — | — | -100,999USD | — | — | 4,000USD | 4,000USD |
| Short Term Investments | — | — | 0USD | 2,049,000USD | 0USD | — | — |
| Accumulated Other Comprehensive Income | — | — | 3,000,000USD | 17,000USD | -16,287,000USD | -12,451USD | 0USD |
| Non Currrent Assets Other | — | — | 100,999USD | — | 6,000USD | 4,000USD | 4,000USD |
| Net Tangible Assets | — | — | — | 8,148,000USD | 15,349,000USD | -14,656,000USD | -10,926,000USD |
| Current Deferred Revenue | — | — | — | — | — | 311,000USD | — |
| Short Long Term Debt | — | — | — | — | — | 2,767,000USD | — |
| Long Term Debt | — | — | — | — | — | 23,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | -3,078,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 6,000USD |
| Stock Based Compensation | 887,000USD |
| Change To Inventory | -194,000USD |
| Change To Liabilities | -180,000USD |
| Change In Working Capital | -346,000USD |
| Operating Cash Flow | -6,576,000USD |
| Capital Expenditures | -71,000USD |
| Investing Cash Flow | -71,000USD |
| Financing Cash Flow | 9,102,000USD |
| Change In Cash | 2,455,000USD |
| End Cash Flow | 9,479,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,521,000USD | -2,941,000USD | -2,912,000USD | -2,895,000USD | -2,420,000USD | -2,878,000USD | -2,471,000USD | -2,389,000USD |
| Depreciation | 1,000USD | 1,000USD | -1,000USD | 1,000USD | 1,000USD | — | 0USD | 0USD |
| Stock Based Compensation | 317,000USD | 285,000USD | 349,000USD | 345,000USD | 288,000USD | 252,000USD | 255,000USD | 244,000USD |
| Other Non Cash Items | 437,000USD | -483,000USD | -152,000USD | 370,000USD | -562,000USD | — | -233,000USD | -508,000USD |
| Change To Account Receivables | -141,000USD | 30,000USD | 194,000USD | -121,000USD | -199,000USD | — | 0USD | 0USD |
| Change To Inventory | -190,000USD | 83,000USD | -272,000USD | — | 0USD | — | — | — |
| Change In Working Capital | -626,000USD | 118,000USD | 446,000USD | -123,000USD | -688,000USD | -142,000USD | 255,000USD | 356,000USD |
| Total Cash From Operating Activities | -3,709,000USD | -3,020,000USD | -2,270,000USD | -2,302,000USD | -3,381,000USD | -2,430,000USD | -2,194,000USD | -2,297,000USD |
| Capital Expenditures | -66,000USD | 0USD | 0USD | 0USD | -2,000USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,709,000USD | -3,020,000USD | -2,270,000USD | -2,302,000USD | -3,383,000USD | -2,442,000USD | -2,194,000USD | -2,297,000USD |
| Total Cashflows From Investing Activities | 66,000USD | — | — | — | -2,000USD | — | — | — |
| Total Cash From Financing Activities | 9,047,000USD | 0USD | 0USD | 34,000USD | 10,811,000USD | 33,000USD | 15,000USD | 9,650,000USD |
| Issuance Of Capital Stock | 10,000,000USD | 0USD | 1,299,000USD | -1,299,000USD | 10,803,000USD | 0USD | 0USD | 9,638,000USD |
| Change In Cash | 5,338,000USD | -3,020,000USD | -2,270,000USD | -2,268,000USD | 7,428,000USD | -2,409,000USD | -2,179,000USD | 7,353,000USD |
| Begin Period Cash Flow | 7,024,000USD | 10,044,000USD | 12,314,000USD | 14,582,000USD | 7,154,000USD | 9,563,000USD | 11,742,000USD | 4,389,000USD |
| End Period Cash Flow | 12,362,000USD | 7,024,000USD | 10,044,000USD | 12,314,000USD | 14,582,000USD | 7,154,000USD | 9,563,000USD | 11,742,000USD |
| Other Cashflows From Financing Activities | 9,047,000USD | — | -1,299,000USD | 34,000USD | 8,000USD | — | 15,000USD | 12,000USD |
| Unclassified Financing Cash Flow | -10,000,000USD | — | — | 1,299,000USD | — | — | — | — |
| Investments | — | — | 0USD | 0USD | -2,000USD | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | -12,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -11,168,000USD | -8,814,000USD | -10,232,000USD | -9,889,000USD | -6,324,000USD | -3,798,000USD | -3,839,000USD |
| Depreciation | 2,000USD | 0USD | 0USD | 6,000USD | 9,000USD | 9,000USD | 9,000USD |
| Stock Based Compensation | 1,267,000USD | 1,174,000USD | 1,078,000USD | 644,000USD | 147,000USD | 50,000USD | 38,000USD |
| Other Non Cash Items | -827,000USD | -1,765,000USD | -1,709,000USD | 644,000USD | 517,000USD | 489,000USD | 8,000USD |
| Change To Account Receivables | -96,000USD | 0USD | — | — | — | — | — |
| Change To Inventory | -189,000USD | 0USD | — | — | — | — | — |
| Change In Working Capital | -247,000USD | 280,000USD | 605,000USD | 428,000USD | -265,000USD | -269,000USD | 443,000USD |
| Total Cash From Operating Activities | -10,973,000USD | -9,125,000USD | -10,258,000USD | -8,811,000USD | -5,916,000USD | -3,528,000USD | -3,350,000USD |
| Capital Expenditures | -2,000USD | -12,000USD | 0USD | 0USD | -15,000USD | -15,000USD | -15,000USD |
| Free Cash Flow | -10,975,000USD | -9,137,000USD | -10,258,000USD | -8,811,000USD | -5,931,000USD | -3,528,000USD | -3,350,000USD |
| Total Cashflows From Investing Activities | -2,000USD | -12,000USD | 2,032,000USD | -2,032,000USD | -15,000USD | -15,000USD | -1,000USD |
| Total Cash From Financing Activities | 10,845,000USD | 15,118,000USD | 5,008,000USD | 42,000USD | 19,328,000USD | 3,199,000USD | 3,199,000USD |
| Issuance Of Capital Stock | 12,102,000USD | 15,016,000USD | 5,000,000USD | 5,000,000USD | 14,563,000USD | 0USD | — |
| Change In Cash | -130,000USD | 5,981,000USD | -3,218,000USD | -10,801,000USD | 13,397,000USD | -329,000USD | -3,351,000USD |
| Begin Period Cash Flow | 7,154,000USD | 1,173,000USD | 4,391,000USD | 15,192,000USD | 1,795,000USD | 2,124,000USD | 5,475,000USD |
| End Period Cash Flow | 7,024,000USD | 7,154,000USD | 1,173,000USD | 4,391,000USD | 15,192,000USD | 1,795,000USD | 2,124,000USD |
| Other Cashflows From Financing Activities | -1,299,000USD | 102,000USD | 8,000USD | 42,000USD | 2,788,000USD | 21,000USD | -1,000USD |
| Investments | — | -12,000USD | 5,008,000USD | -2,032,000USD | -15,000USD | -2,032,000USD | -1,000USD |
| Unclassified Investing Cash Flow | — | — | -2,976,000USD | — | — | 2,032,000USD | — |
| Change To Liabilities | — | — | — | 0USD | 363,000USD | -376,000USD | 343,000USD |
| Net Borrowings | — | — | — | 0USD | 1,977,000USD | 3,178,000USD | 3,178,000USD |
| Other Cashflows From Investing Activities | — | — | — | -2,032USD | -15,000USD | — | -1,000USD |
| Unclassified Financing Cash Flow | — | — | — | -5,000,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.